These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16309005)

  • 1. Electrocardiogram changes in hyperkalemia: there and back again.
    Zimlichman E; Liran O
    Isr Med Assoc J; 2005 Nov; 7(11):748. PubMed ID: 16309005
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal ECG or peaked T waves?
    Hancock EW
    Hosp Pract (1995); 1998 May; 33(5):19-20. PubMed ID: 9606350
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
    Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH
    BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459
    [No Abstract]   [Full Text] [Related]  

  • 5. Life-threatening hyperkalemia: a potentially lethal drug combination.
    Juvet T; Gourineni VC; Ravi S; Zarich SW
    Conn Med; 2013 Sep; 77(8):491-3. PubMed ID: 24156179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
    Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D
    Ugeskr Laeger; 2004 Sep; 166(37):3201-3. PubMed ID: 15384373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
    Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic detection of spironolactone - related adverse drug events.
    Huang C; Noirot LA; Reichley RM; Bouselli DA; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2005; 2005():989. PubMed ID: 16779276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
    Lenz T
    MMW Fortschr Med; 2005 Jan; 147(4):59-60. PubMed ID: 15745346
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spironolactone and potassium].
    Kjeldsen K
    Ugeskr Laeger; 2004 Nov; 166(48):4392; author reply 4392-3. PubMed ID: 15587639
    [No Abstract]   [Full Text] [Related]  

  • 11. [CMF-ECG 19/Solution. Electrolyte disturbance].
    Brunckhorst CB
    Praxis (Bern 1994); 2007 Oct; 96(43):1691-2. PubMed ID: 18019181
    [No Abstract]   [Full Text] [Related]  

  • 12. Peri-anaesthetic cardiac arrest with administration of enalapril, spironolactone and β-blocker.
    Basquin C; Simeon C; Gentili ME
    Anaesthesiol Intensive Ther; 2018; 50(4):323. PubMed ID: 30284714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure drug poses potassium problems. When using "the water pill" spironolactone, watch your potassium intake and check your levels.
    Harv Heart Lett; 2004 Dec; 15(4):3. PubMed ID: 15704264
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug safety in patients with heart failure.
    Juurlink DN; Hansten PD
    Arch Intern Med; 2005 Jan; 165(1):118. PubMed ID: 15642888
    [No Abstract]   [Full Text] [Related]  

  • 15. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract]   [Full Text] [Related]  

  • 16. Extrarenal effects of diuretic agents.
    Riecker G
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):106-10. PubMed ID: 4924317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence of hyperkalemia caused by Aldactone therapy and its significance in decompensated liver cirrhosis].
    Radó J; Marosi J; Takó J
    Orv Hetil; 1968 Sep; 109(35):1911-4. PubMed ID: 5714832
    [No Abstract]   [Full Text] [Related]  

  • 18. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
    Berry C; McMurray J
    Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications during enalapril and diuretic therapy for congestive cardiac failure.
    Mehta S; Vijayakumar M
    Indian J Pediatr; 2009 Sep; 76(9):963-4. PubMed ID: 19904515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.